Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records-Reference-Cited by-同舟云学术

Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records

Published:2018-06 Issue: Volume:111 Page:429-435
ISSN:0091-7435
Container-title:Preventive Medicine
language:en
Short-container-title:Preventive Medicine

Author:

Landy Rebecca^ORCID,Cheung Li C.,Schiffman Mark,Gage Julia C.,Hyun Noorie,Wentzensen Nicolas,Kinney Walter K.,Castle Philip E.,Fetterman Barbara,Poitras Nancy E.,Lorey Thomas,Sasieni Peter D.,Katki Hormuzd A.

Funder

Union for International Cancer Control Yamagiwa-Yoshida

Cancer Research UK

National Cancer Institute

National Institutes of Health

U.S. Department of Health and Human Services

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Epidemiology

Reference19 articles.

1. The age distribution of cancer and a multi-stage theory of carcinogenesis;Armitage;Br. J. Cancer,1954

2. Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records;Cheung;Stat. Med.,2017

3. Overview of the European and North American studies on HPV testing in primary cervical cancer screening;Cuzick;Int. J. Cancer,2006

4. Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology—results from the Hammersmith study;Cuzick;Int. J. Cancer,2008

5. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study;Dillner;BMJ,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Untreated cervical intraepithelial neoplasia grade 2 and subsequent risk of cervical cancer: population based cohort study;BMJ;2023-11-29

2. The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma;Gynecologic Oncology;2023-07

3. The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics;Cancer Epidemiology Biomarkers & Prevention;2021-11-17

4. Influential Usage of Big Data and Artificial Intelligence in Healthcare;Computational and Mathematical Methods in Medicine;2021-09-06

5. The confounding effect of multi-type human papillomavirus infections on type-specific natural history parameter identification;Epidemics;2021-09